PMID- 10612508 OWN - NLM STAT- MEDLINE DCOM- 19991228 LR - 20190627 IS - 0002-9394 (Print) IS - 0002-9394 (Linking) VI - 128 IP - 6 DP - 1999 Dec TI - A novel mutation in the ABCR gene in four patients with autosomal recessive Stargardt disease. PG - 720-4 AB - PURPOSE: To identify additional mutations in the ABCR gene and describe the clinical features of four affected siblings with autosomal recessive Stargardt disease. METHODS: A cohort of eight siblings was identified for study. Four of these individuals were diagnosed with Stargardt disease based on clinical evaluation and fluorescein angiography. Blood samples were obtained from seven of eight siblings, including all those affected. All 50 exons of the ABCR gene were analyzed by single-stranded confirmation polymorphism analysis, followed by direct sequencing of observed variants, to identify mutations in the ABCR gene. RESULTS: We identified a previously unreported kindred of eight siblings, four of whom had mutations in both of their ABCR alleles. A previously described G-to-C transversion of nucleotide 2588, predicting a Gly863Ala amino acid substitution, and a novel G-to-A transition of nucleotide 161, resulting in a Cys54Tyr substitution, were identified. These mutations co-segregated with the affected members of this family. Three of the siblings demonstrated clinical features characteristic of classic Stargardt disease, with bilateral regions of macular atrophy associated with yellow-white "flavimaculatus" flecks in the posterior pole at the level of the retinal pigment epithelium. The fourth affected sibling showed features of early Stargardt disease, with a beaten-bronze appearance to both maculas, as well as perimacular flecks. In all four affected patients, fluorescein angiography showed a characteristic peripheral dark choroid. CONCLUSIONS: We have identified both a previously described and a novel mutation in the ABCR gene in four patients with autosomal recessive Stargardt disease. In-depth knowledge of the ABCR mutation spectrum in patients with Stargardt disease will provide for more efficient screening and may provide potential therapies for Stargardt disease and other retinal diseases. FAU - Zhang, K AU - Zhang K AD - Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. zhangk@welchlink.welch.jhu.edu FAU - Garibaldi, D C AU - Garibaldi DC FAU - Kniazeva, M AU - Kniazeva M FAU - Albini, T AU - Albini T FAU - Chiang, M F AU - Chiang MF FAU - Kerrigan, M AU - Kerrigan M FAU - Sunness, J S AU - Sunness JS FAU - Han, M AU - Han M FAU - Allikmets, R AU - Allikmets R LA - eng GR - N01-CO-56000/CO/NCI NIH HHS/United States PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Am J Ophthalmol JT - American journal of ophthalmology JID - 0370500 RN - 0 (ABCA4 protein, human) RN - 0 (ATP-Binding Cassette Transporters) SB - IM MH - ATP-Binding Cassette Transporters/*genetics MH - Adult MH - Base Sequence MH - Cohort Studies MH - DNA Mutational Analysis MH - Eye Diseases, Hereditary/*genetics/pathology MH - Female MH - Fluorescein Angiography MH - Fundus Oculi MH - Humans MH - Macular Degeneration/*genetics/pathology MH - Middle Aged MH - Molecular Sequence Data MH - Pedigree MH - *Point Mutation MH - Polymorphism, Single-Stranded Conformational MH - Sequence Analysis, DNA MH - Visual Acuity EDAT- 1999/12/28 00:00 MHDA- 1999/12/28 00:01 CRDT- 1999/12/28 00:00 PHST- 1999/12/28 00:00 [pubmed] PHST- 1999/12/28 00:01 [medline] PHST- 1999/12/28 00:00 [entrez] AID - S0002939499002366 [pii] AID - 10.1016/s0002-9394(99)00236-6 [doi] PST - ppublish SO - Am J Ophthalmol. 1999 Dec;128(6):720-4. doi: 10.1016/s0002-9394(99)00236-6.